gadolinium dtpa has been researched along with zd 6126 in 2 studies
| Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (zd 6126) | Trials (zd 6126) | Recent Studies (post-2010) (zd 6126) |
|---|---|---|---|---|---|
| 12,654 | 664 | 4,051 | 76 | 2 | 12 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blakey, DC; Corbett, TH; DelProposto, Z; Evelhoch, JL; He, Z; Langmuir, P; Leadbetter, J; LoRusso, PM; Polin, L; Ryan, AJ; Stone, A; Waterton, JC; Wheeler, C | 1 |
| Artemov, D; Bhujwalla, ZM; Gimi, B; Vogel-Claussen, J | 1 |
2 other study(ies) available for gadolinium dtpa and zd 6126
| Article | Year |
|---|---|
Magnetic resonance imaging measurements of the response of murine and human tumors to the vascular-targeting agent ZD6126.
Topics: Angiogenesis Inhibitors; Animals; Area Under Curve; Cell Line, Tumor; Cell Proliferation; Contrast Media; Dose-Response Relationship, Drug; Female; Gadolinium DTPA; Humans; Kinetics; Magnetic Resonance Imaging; Male; Mice; Necrosis; Organophosphorus Compounds; Time Factors; Treatment Outcome | 2004 |
Diffusion-weighted and macromolecular contrast enhanced MRI of tumor response to antivascular therapy with ZD6126.
Topics: Albumins; Animals; Cell Line, Tumor; Contrast Media; Diffusion; Diffusion Magnetic Resonance Imaging; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Mice; Mice, SCID; Necrosis; Neoplasm Transplantation; Neoplasms; Organophosphorus Compounds; Time Factors | 2007 |